# A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection

> **NCT02453789** · PHASE2 · COMPLETED · sponsor: **AlgiPharma AS** · enrollment: 15 (actual)

## Conditions studied

- Cystic Fibrosis
- Burkholderia Infection

## Interventions

- **DRUG:** Alginate oligosaccharide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02453789
- **Lead sponsor:** AlgiPharma AS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-03
- **Final completion:** 2017-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02453789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02453789, "A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02453789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*